Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neuroblastoma 8Head and Neck Neoplasms 2Ganglioneuroblastoma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Uterine Cervical Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Oligodendroglioma 1Medulloblastoma 1Lung Neoplasms 1Kidney Neoplasms 1HIV Infections 1Gliosarcoma 1Glioma 1Glioblastoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Cancer Female 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Doxorubicin 6Vincristine 4Liposomes 4Bleomycin 4Fluorouracil 2sargramostim 1liposomal doxorubicin 1Zidovudine 1Watchful Waiting 1Radiotherapy 1Paclitaxel 1Observation 1Methotrexate 1Light Coagulation 1Leucovorin 1Laser Therapy 1Isotretinoin 1Imiquimod 1Dexamethasone 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Acquired Immunodeficiency Syndrome × Isotretinoin × Clear all
NCT00001073 2021-11-04

Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
150 enrolled
Gynecologic

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Uterine Cervical Diseases, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡